ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $21,642 | +86.2% | 4,820 | +82.9% | 0.01% | +83.3% |
| Q3 2023 | $11,620 | -32.4% | 2,635 | 0.0% | 0.01% | -40.0% |
| Q2 2023 | $17,180 | -9.6% | 2,635 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $18,998 | -23.9% | 2,635 | 0.0% | 0.01% | -35.3% |
| Q4 2022 | $24,978 | -10.8% | 2,635 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $28,000 | +3.7% | 2,635 | 0.0% | 0.02% | +5.3% |
| Q2 2022 | $27,000 | +17.4% | 2,635 | +9.6% | 0.02% | +26.7% |
| Q1 2022 | $23,000 | -20.7% | 2,405 | 0.0% | 0.02% | -21.1% |
| Q4 2021 | $29,000 | -43.1% | 2,405 | 0.0% | 0.02% | -48.6% |
| Q3 2021 | $51,000 | +54.5% | 2,405 | +46.2% | 0.04% | +48.0% |
| Q2 2021 | $33,000 | +3200.0% | 1,645 | +3555.6% | 0.02% | +2400.0% |
| Q1 2021 | $1,000 | -50.0% | 45 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $2,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |